These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 14612974)
1. Heparanase messenger RNA expression in epithelial ovarian tumor. Kodama J; Shinyo Y; Hashen G; Hongo A; Yoshinouchi M; Hiramatsu Y Int J Mol Med; 2003 Dec; 12(6):961-4. PubMed ID: 14612974 [TBL] [Abstract][Full Text] [Related]
2. Heparanase expression in human colorectal cancer and its relationship to tumor angiogenesis, hematogenous metastasis, and prognosis. Sato T; Yamaguchi A; Goi T; Hirono Y; Takeuchi K; Katayama K; Matsukawa S J Surg Oncol; 2004 Sep; 87(4):174-81. PubMed ID: 15334632 [TBL] [Abstract][Full Text] [Related]
3. [The expression of acetyl-heparanase, laminin and laminin receptor and their role in the metastasis of ovarian cancer]. Liu Y; Xin XY; Han LF; Wang DT Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Sep; 19(5):459-61. PubMed ID: 15169656 [TBL] [Abstract][Full Text] [Related]
4. Heparanase gene expression and metastatic potential in human gastric cancer. Endo K; Maejara U; Baba H; Tokunaga E; Koga T; Ikeda Y; Toh Y; Kohnoe S; Okamura T; Nakajima M; Sugimachi K Anticancer Res; 2001; 21(5):3365-9. PubMed ID: 11848495 [TBL] [Abstract][Full Text] [Related]
5. Detection of peritoneal micrometastasis by reverse transcriptase-polymerase chain reaction for heparanase mRNA and cytology in peritoneal wash samples. Wang Z; Zhang X; Xu H; Zhou X; Jiang L; Lu C J Surg Oncol; 2005 May; 90(2):59-65. PubMed ID: 15844185 [TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of heparanase messenger RNA expression in hepatocellular carcinoma. Ikeguchi M; Ueta T; Yamane Y; Hirooka Y; Kaibara N J Surg Oncol; 2002 Nov; 81(3):148-54; disscusion 154. PubMed ID: 12407728 [TBL] [Abstract][Full Text] [Related]
7. Heparanase expression at the invasion front of human head and neck cancers and correlation with poor prognosis. Beckhove P; Helmke BM; Ziouta Y; Bucur M; Dörner W; Mogler C; Dyckhoff G; Herold-Mende C Clin Cancer Res; 2005 Apr; 11(8):2899-906. PubMed ID: 15837740 [TBL] [Abstract][Full Text] [Related]
8. Expression and localization of aquaporin-5 in the epithelial ovarian tumors. Yang JH; Shi YF; Cheng Q; Deng L Gynecol Oncol; 2006 Feb; 100(2):294-9. PubMed ID: 16242760 [TBL] [Abstract][Full Text] [Related]
9. [Expression of heparanase mRNA and its clinical significance in primary hepatocellular carcinoma]. Zhang YL; Fu ZR; Ding GS; Fu H; Wang YH; Wang Q Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):359-61. PubMed ID: 12921566 [TBL] [Abstract][Full Text] [Related]
10. [Protein and mRNA expression of aquaporin-1 in epithelial ovarian tumors and its clinic significance]. Yang JH; Shi YF; Cheng Q; Qian YL Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):623-6. PubMed ID: 16202320 [TBL] [Abstract][Full Text] [Related]
11. Decreased luteinizing hormone receptor mRNA expression in human ovarian epithelial cancer. Lu JJ; Zheng Y; Kang X; Yuan JM; Lauchlan SC; Pike MC; Zheng W Gynecol Oncol; 2000 Nov; 79(2):158-68. PubMed ID: 11063638 [TBL] [Abstract][Full Text] [Related]
12. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis. Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057 [TBL] [Abstract][Full Text] [Related]
13. The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms. Wang P; Wu X; Chen W; Liu J; Wang X Gynecol Oncol; 2007 Mar; 104(3):714-20. PubMed ID: 17204312 [TBL] [Abstract][Full Text] [Related]
14. [Inhibitory effect of silencing heparanase expression with antisense oligodeoxynucleotide on invasive capability of human esophageal squamous cancer cell line TE-13]. Zhu H; Wang SJ; Wang SX; Meng XL; Wang YJ Ai Zheng; 2005 Dec; 24(12):1431-5. PubMed ID: 16351787 [TBL] [Abstract][Full Text] [Related]
15. Heparanase: a key enzyme in invasion and metastasis of gastric carcinoma. Tang W; Nakamura Y; Tsujimoto M; Sato M; Wang X; Kurozumi K; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K Mod Pathol; 2002 Jun; 15(6):593-8. PubMed ID: 12065771 [TBL] [Abstract][Full Text] [Related]
16. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer. Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549 [TBL] [Abstract][Full Text] [Related]
17. Heparanase expression correlates with poor survival in metastatic ovarian carcinoma. Davidson B; Shafat I; Risberg B; Ilan N; Trope' CG; Vlodavsky I; Reich R Gynecol Oncol; 2007 Feb; 104(2):311-9. PubMed ID: 17030350 [TBL] [Abstract][Full Text] [Related]
18. [Relationship between heparanase mRNA expression in human gastric cancer and its clinicopathological features]. Chen JQ; Zhan WH; He YL; Peng JS; Wang JP; Chen ZX; Huang YH; Cai SR Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):609-11. PubMed ID: 15634522 [TBL] [Abstract][Full Text] [Related]
19. Heparanase protein and gene expression in bladder cancer. Gohji K; Okamoto M; Kitazawa S; Toyoshima M; Dong J; Katsuoka Y; Nakajima M J Urol; 2001 Oct; 166(4):1286-90. PubMed ID: 11547059 [TBL] [Abstract][Full Text] [Related]
20. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer. Kusuda T; Shigemasa K; Arihiro K; Fujii T; Nagai N; Ohama K Oncol Rep; 2005 Jun; 13(6):1153-8. PubMed ID: 15870936 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]